Dennis Goldberg

Title: Dennis Goldberg: Innovator in Cholesterol Management

Introduction

Dennis Goldberg is an accomplished inventor based in Sudbury, MA (US). He has made significant contributions to the field of lipid and metabolic disorders through his innovative research and patenting efforts. His work focuses on developing therapeutic agents that can effectively reduce plasma cholesterol levels.

Latest Patents

Goldberg holds a patent for "APOE mimetic peptides and higher potency to clear plasma cholesterol." This patent discloses synthetic apolipoprotein E-mimicking peptides and their derivatives, which are useful as therapeutic agents for reducing plasma cholesterol. The patent also outlines synthetic methods for creating these peptides, pharmaceutical compositions that include them, and methods for treating lipid and metabolic disorders using these innovative compounds.

Career Highlights

Throughout his career, Dennis Goldberg has worked with notable organizations, including the UAB Research Foundation and Anji Pharmaceuticals Inc. His experience in these institutions has allowed him to advance his research and contribute to the development of effective treatments for cholesterol-related health issues.

Collaborations

One of his notable collaborators is Gattadahalli M Anantharamaiah, with whom he has worked on various projects related to his patent and research in cholesterol management.

Conclusion

Dennis Goldberg's innovative work in developing APOE mimetic peptides represents a significant advancement in the treatment of lipid and metabolic disorders. His contributions continue to impact the field of cholesterol management positively.